at 7% (n ¼ 17). Overall, there has been a significant trend toward increased vascular operative consultations during the study period (Fig).
Objective: Practice management in vascular surgery requires a delicate balance of elective procedures both within and outside of hospital-based settings paired with readily available emergency surgical capabilities. Several recent studies have emphasized that emergency vascular surgery as well as intraoperative assistance to other surgical and interventional specialties represents a substantial portion of vascular surgical practice, especially in a university-based setting. One solution to this balance is a vascular hospitalist setup, or on-service model, whereby one surgeon is dedicated to the inpatient service and available to cover any urgent or emergent cases. Whereas this is well described in the acute care surgery and trauma population, few studies describe a vascular surgery hospitalist model. Our institution started an on-service model in 2013, and we sought to evaluate the impact on the surgeon's productivity. Our hypothesis was that the on-service model would maintain in-hospital volume and allow increased productivity at offsite and outreach facilities where predominantly elective procedures are performed.
Methods: Departmental databases were queried for procedure numbers, work relative value units, and charges performed by vascular surgeons within the health care system. Comparison was made before and after initiation of the on-service model, which occurred in August 2013 (fiscal year 2014), of the group of surgeons involved in on-service coverage. In addition, the data were stratified on the basis of location at the main university hospital compared with offsite and outreach facilities. Total relative value units during the 2 years before initiation of the on-service model were averaged to create a baseline at both the university hospital and offsite facilities. This was compared with the following 4 years expressed as percentage growth over baseline.
Results: We found that the overall productivity within the university hospital was relatively stable in year 1 and year 2 (3% and À3%), with a slight increase in year 3 and year 4 (13% and 7%). The offsite facilities, however, demonstrated a more significant increase during this time at 6%, 11%, 34%, and 31% at years 1 to 4 over the original baseline. Total productivity demonstrated growth over baseline in all 4 years (4%, 1%, 19%, 14%).
Conclusions: The on-service model preserved university hospital productivity with an increase in the productivity in the offsite facilities of the providers involved in on-service coverage. This model of vascular coverage allows consistent inpatient management and readily available emergency vascular surgery coverage but also development of elective and outreach practice, demonstrating a viable strategy for vascular surgery practice management.
Author Disclosures: D. Harris: Nothing to disclose; C. E. Morgan: Nothing to disclose. Objective: Carotid revascularization carries less cardiac morbidity and physiologic stress compared with other major vascular interventions. Thus, surgeons might overlook the effects of anemia in patients undergoing carotid endarterectomy (CEA) or carotid artery stenting (CAS). We aimed to study the association between anemia and major adverse outcomes after CEA and CAS.
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Anemia as an Independent Predictor of Adverse Outcomes After Carotid Revascularization
Methods: A retrospective analysis of the American College of Surgeons National Surgical Quality Improvement Program targeted database (2011-2016) was performed. Anemia was defined, according to the World Health Organization, as a hematocrit level of <36% in nonpregnant women and <39% in men. Multivariate logistic regression models adjusting for different characteristics of the patients were used to study the association between anemia and major adverse cardiac events (MACEs), defined as the occurrence of 30-day stroke, death, myocardial infarction, or cardiac arrest. Further 1:1 coarsened exact matching was performed on the basis of procedure type, age, sex, race, ethnicity, body mass index, diabetes, hypertension, congestive heart failure, chronic kidney disease, dialysis, bleeding disorders, American Society of Anesthesiologists class, physiologic and anatomic risk, preoperative statin and beta blocker use, smoking history, and emergency status.
Results: A total of 21,799 patients were included, of whom 33.7% were anemic (CEA, 33.5%; CAS, 41.5%). Anemic patients were older and had more comorbid conditions compared with nonanemic patients (Table) . The incidence of stroke was similar between the two groups (2.5% vs 2.2%; P ¼ .10). However, anemic patients had higher rates of 30-day mortality (1.2% vs 0.4%), myocardial infarction (1.7% vs 0.9%), cardiac 
01).
Conclusions: Anemia is associated with almost 50% increased risk of MACEs after carotid revascularization and should be incorporated into the operative risk assessment. Optimization of preoperative anemia and management of the disease processes that accentuate it are warranted to improve the outcomes of anemic patients.
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Intravenous Anti-inflammatory Agent Reduces Mortality and Morbidity After Open Abdominal Aortic Aneurysm Repair Objective: The role of nonsteroidal anti-inflammatory drugs (NSAIDs) in aortic aneurysm disease progression and prognosis has been debated because of their effect on the inflammatory pathways attributed to abdominal aortic aneurysm (AAA) disease. Animal studies demonstrated that intrathecal ketorolac (Toradol) reduces the inflammatory response associated with aortic clamping, a classic ischemiareperfusion injury example. However, no study of human patients evaluated this association. Therefore, we sought to explore the effects of ketorolac use in open AAA repair (OAR) on mortality and complications. 
